Laboratory, electrocardiographic and risk scoring results of the study population by levels of sex-minute walk test distance.

<p>Data are presented as mean ± standard deviation, number (%) of patients.</p><p>*Compared using ANOVA test.</p>†<p>Compared using Chi-square or Fisher exact test. TIMI =  Thrombolysis In Myocardial Infarction; CK =  creatine kinase; 6MWT =  sex-minute walk test; <i>GRACE</i> =  Global Registry of Acute Coronary Events; NS = not significant.</p

Clinical outcomes and complications at 90 days follow-up in the study population by levels of sex-minute walk test distance.

<p>Data are presented as number (%) of patients.</p>†<p>Compared using Chi-square or Fisher exact test. MACE =  major adverse cardiac events; MI =  myocardial infarction.</p

Logistic regression analysis for prediction of MACE.

<p>MI: myocardial infarction, PPCI: primary percutanious coronary intervention, TIMI =  Thrombolysis In Myocardial Infarction; CK =  creatine kinase; 6MWT =  sex-minute walk test; <i>GRACE</i> =  Global Registry of Acute Coronary Events.</p

Baseline characteristics of the study population by levels of sex-minute walk test distance.

<p>Data are presented as mean ± standard deviation, number (%) of patients.</p><p>*Compared using ANOVA test.</p>†<p>Compared using Chi-square or Fisher exact test. BP =  blood pressure; MI =  myocardial infarction; TIMI =  Thrombolysis In Myocardial Infarction; CK =  creatine kinase; 6MWT =  sex-minute walk test; PCI =  percutaneous coronary intervention; CABG = coronary artery bypass graft; NS = not significant.</p